$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
飞尼妥的使用说明书
2025-10-19 11:44:20
Check Details
什么情况要停用阿昔替尼?
2025-10-19 11:44:20
Check Details
依维莫司的用法及用量
2025-10-19 11:44:20
Check Details
阿昔替尼说明书
2025-10-19 11:44:20
Check Details
舒尼替尼 价格
2025-10-19 11:44:20
Check Details
阿昔替尼治疗肾癌效果
2025-10-19 11:44:20
Check Details
阿昔替尼治疗肾癌时推荐剂量
2025-10-19 11:44:20
Check Details
阿昔替尼入医保后多少钱?
2025-10-19 11:44:20
Check Details
阿昔替尼医保吗?
2025-10-19 11:44:20
Check Details
抗癌药英利达
2025-10-19 11:44:20
Check Details
飞尼妥 说明书
2025-10-19 11:44:20
Check Details
英利达抗癌药说明书
2025-10-19 11:44:20
Check Details
1
2
...
2134
2135
2136
2137
2138
2139
2140
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
2
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
3
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
4
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
5
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
6
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
7
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
8
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
9
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide